Report Detail
Global Antibody-drug Conjugates Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
- RnM4654885 |
- 05 December, 2025 |
- Global |
- 80 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Antibody-drug Conjugates market size was valued at US$ 3191 million in 2024 and is forecast to a readjusted size of USD 4354 million by 2031 with a CAGR of 4.6% during review period.
Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue.
North America is the largest market with about 59% market share. Europe is follower, accounting for about 27% market share.
The key players are ImmunoGen, Seattle Genetics, Roche, Takeda etc. Takeda is the largest manufacturer with about 57% revenue market share.
This report is a detailed and comprehensive analysis for global Antibody-drug Conjugates market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Antibody-drug Conjugates market size and forecasts, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/Kg), 2020-2031
Global Antibody-drug Conjugates market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/Kg), 2020-2031
Global Antibody-drug Conjugates market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Kg), and average selling prices (USD/Kg), 2020-2031
Global Antibody-drug Conjugates market shares of main players, shipments in revenue ($ Million), sales quantity (Kg), and ASP (USD/Kg), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Antibody-drug Conjugates
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Antibody-drug Conjugates market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ImmunoGen, Seattle Genetics, Roche, Takeda, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Antibody-drug Conjugates market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Adcetris
Kadcyla
Market segment by Application
Breast Cancer
Lymphoma
Major players covered
ImmunoGen
Seattle Genetics
Roche
Takeda
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Antibody-drug Conjugates product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Antibody-drug Conjugates, with price, sales quantity, revenue, and global market share of Antibody-drug Conjugates from 2020 to 2025.
Chapter 3, the Antibody-drug Conjugates competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Antibody-drug Conjugates breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Antibody-drug Conjugates market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Antibody-drug Conjugates.
Chapter 14 and 15, to describe Antibody-drug Conjugates sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Antibody-drug Conjugates Consumption Value by Type: 2020 Versus 2024 Versus 2031
- 1.3.2 Adcetris
- 1.3.3 Kadcyla
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Antibody-drug Conjugates Consumption Value by Application: 2020 Versus 2024 Versus 2031
- 1.4.2 Breast Cancer
- 1.4.3 Lymphoma
- 1.5 Global Antibody-drug Conjugates Market Size & Forecast
- 1.5.1 Global Antibody-drug Conjugates Consumption Value (2020 & 2024 & 2031)
- 1.5.2 Global Antibody-drug Conjugates Sales Quantity (2020-2031)
- 1.5.3 Global Antibody-drug Conjugates Average Price (2020-2031)
2 Manufacturers Profiles
- 2.1 ImmunoGen
- 2.1.1 ImmunoGen Details
- 2.1.2 ImmunoGen Major Business
- 2.1.3 ImmunoGen Antibody-drug Conjugates Product and Services
- 2.1.4 ImmunoGen Antibody-drug Conjugates Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.1.5 ImmunoGen Recent Developments/Updates
- 2.2 Seattle Genetics
- 2.2.1 Seattle Genetics Details
- 2.2.2 Seattle Genetics Major Business
- 2.2.3 Seattle Genetics Antibody-drug Conjugates Product and Services
- 2.2.4 Seattle Genetics Antibody-drug Conjugates Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.2.5 Seattle Genetics Recent Developments/Updates
- 2.3 Roche
- 2.3.1 Roche Details
- 2.3.2 Roche Major Business
- 2.3.3 Roche Antibody-drug Conjugates Product and Services
- 2.3.4 Roche Antibody-drug Conjugates Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.3.5 Roche Recent Developments/Updates
- 2.4 Takeda
- 2.4.1 Takeda Details
- 2.4.2 Takeda Major Business
- 2.4.3 Takeda Antibody-drug Conjugates Product and Services
- 2.4.4 Takeda Antibody-drug Conjugates Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
- 2.4.5 Takeda Recent Developments/Updates
3 Competitive Environment: Antibody-drug Conjugates by Manufacturer
- 3.1 Global Antibody-drug Conjugates Sales Quantity by Manufacturer (2020-2025)
- 3.2 Global Antibody-drug Conjugates Revenue by Manufacturer (2020-2025)
- 3.3 Global Antibody-drug Conjugates Average Price by Manufacturer (2020-2025)
- 3.4 Market Share Analysis (2024)
- 3.4.1 Producer Shipments of Antibody-drug Conjugates by Manufacturer Revenue ($MM) and Market Share (%): 2024
- 3.4.2 Top 3 Antibody-drug Conjugates Manufacturer Market Share in 2024
- 3.4.3 Top 6 Antibody-drug Conjugates Manufacturer Market Share in 2024
- 3.5 Antibody-drug Conjugates Market: Overall Company Footprint Analysis
- 3.5.1 Antibody-drug Conjugates Market: Region Footprint
- 3.5.2 Antibody-drug Conjugates Market: Company Product Type Footprint
- 3.5.3 Antibody-drug Conjugates Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Antibody-drug Conjugates Market Size by Region
- 4.1.1 Global Antibody-drug Conjugates Sales Quantity by Region (2020-2031)
- 4.1.2 Global Antibody-drug Conjugates Consumption Value by Region (2020-2031)
- 4.1.3 Global Antibody-drug Conjugates Average Price by Region (2020-2031)
- 4.2 North America Antibody-drug Conjugates Consumption Value (2020-2031)
- 4.3 Europe Antibody-drug Conjugates Consumption Value (2020-2031)
- 4.4 Asia-Pacific Antibody-drug Conjugates Consumption Value (2020-2031)
- 4.5 South America Antibody-drug Conjugates Consumption Value (2020-2031)
- 4.6 Middle East & Africa Antibody-drug Conjugates Consumption Value (2020-2031)
5 Market Segment by Type
- 5.1 Global Antibody-drug Conjugates Sales Quantity by Type (2020-2031)
- 5.2 Global Antibody-drug Conjugates Consumption Value by Type (2020-2031)
- 5.3 Global Antibody-drug Conjugates Average Price by Type (2020-2031)
6 Market Segment by Application
- 6.1 Global Antibody-drug Conjugates Sales Quantity by Application (2020-2031)
- 6.2 Global Antibody-drug Conjugates Consumption Value by Application (2020-2031)
- 6.3 Global Antibody-drug Conjugates Average Price by Application (2020-2031)
7 North America
- 7.1 North America Antibody-drug Conjugates Sales Quantity by Type (2020-2031)
- 7.2 North America Antibody-drug Conjugates Sales Quantity by Application (2020-2031)
- 7.3 North America Antibody-drug Conjugates Market Size by Country
- 7.3.1 North America Antibody-drug Conjugates Sales Quantity by Country (2020-2031)
- 7.3.2 North America Antibody-drug Conjugates Consumption Value by Country (2020-2031)
- 7.3.3 United States Market Size and Forecast (2020-2031)
- 7.3.4 Canada Market Size and Forecast (2020-2031)
- 7.3.5 Mexico Market Size and Forecast (2020-2031)
8 Europe
- 8.1 Europe Antibody-drug Conjugates Sales Quantity by Type (2020-2031)
- 8.2 Europe Antibody-drug Conjugates Sales Quantity by Application (2020-2031)
- 8.3 Europe Antibody-drug Conjugates Market Size by Country
- 8.3.1 Europe Antibody-drug Conjugates Sales Quantity by Country (2020-2031)
- 8.3.2 Europe Antibody-drug Conjugates Consumption Value by Country (2020-2031)
- 8.3.3 Germany Market Size and Forecast (2020-2031)
- 8.3.4 France Market Size and Forecast (2020-2031)
- 8.3.5 United Kingdom Market Size and Forecast (2020-2031)
- 8.3.6 Russia Market Size and Forecast (2020-2031)
- 8.3.7 Italy Market Size and Forecast (2020-2031)
9 Asia-Pacific
- 9.1 Asia-Pacific Antibody-drug Conjugates Sales Quantity by Type (2020-2031)
- 9.2 Asia-Pacific Antibody-drug Conjugates Sales Quantity by Application (2020-2031)
- 9.3 Asia-Pacific Antibody-drug Conjugates Market Size by Region
- 9.3.1 Asia-Pacific Antibody-drug Conjugates Sales Quantity by Region (2020-2031)
- 9.3.2 Asia-Pacific Antibody-drug Conjugates Consumption Value by Region (2020-2031)
- 9.3.3 China Market Size and Forecast (2020-2031)
- 9.3.4 Japan Market Size and Forecast (2020-2031)
- 9.3.5 South Korea Market Size and Forecast (2020-2031)
- 9.3.6 India Market Size and Forecast (2020-2031)
- 9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
- 9.3.8 Australia Market Size and Forecast (2020-2031)
10 South America
- 10.1 South America Antibody-drug Conjugates Sales Quantity by Type (2020-2031)
- 10.2 South America Antibody-drug Conjugates Sales Quantity by Application (2020-2031)
- 10.3 South America Antibody-drug Conjugates Market Size by Country
- 10.3.1 South America Antibody-drug Conjugates Sales Quantity by Country (2020-2031)
- 10.3.2 South America Antibody-drug Conjugates Consumption Value by Country (2020-2031)
- 10.3.3 Brazil Market Size and Forecast (2020-2031)
- 10.3.4 Argentina Market Size and Forecast (2020-2031)
11 Middle East & Africa
- 11.1 Middle East & Africa Antibody-drug Conjugates Sales Quantity by Type (2020-2031)
- 11.2 Middle East & Africa Antibody-drug Conjugates Sales Quantity by Application (2020-2031)
- 11.3 Middle East & Africa Antibody-drug Conjugates Market Size by Country
- 11.3.1 Middle East & Africa Antibody-drug Conjugates Sales Quantity by Country (2020-2031)
- 11.3.2 Middle East & Africa Antibody-drug Conjugates Consumption Value by Country (2020-2031)
- 11.3.3 Turkey Market Size and Forecast (2020-2031)
- 11.3.4 Egypt Market Size and Forecast (2020-2031)
- 11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
- 11.3.6 South Africa Market Size and Forecast (2020-2031)
12 Market Dynamics
- 12.1 Antibody-drug Conjugates Market Drivers
- 12.2 Antibody-drug Conjugates Market Restraints
- 12.3 Antibody-drug Conjugates Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Antibody-drug Conjugates and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Antibody-drug Conjugates
- 13.3 Antibody-drug Conjugates Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Antibody-drug Conjugates Typical Distributors
- 14.3 Antibody-drug Conjugates Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Antibody-drug Conjugates. Industry analysis & Market Report on Antibody-drug Conjugates is a syndicated market report, published as Global Antibody-drug Conjugates Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031. It is complete Research Study and Industry Analysis of Antibody-drug Conjugates market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
